A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells

A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells Pages 1691-1704 Brian W. Soper, Ted M. Duffy, Carole A. Vogler, Jane E. Barker Preview Purchase PDF (2671 K) | Related Articles Abstract Abstract Causes of transplantation failures are often difficult to assess due to our inability to monitor hematopoietic stem cell (HSC) homing, distribution, and amplification in situ. We have developed a mouse model that permits histochemical localization of 1000-fold enriched HSC and quantification of their long-term expanded progeny in situ. The mice are genetically myeloablated (c-kit receptor mutated, W41/W41) and are β-glucuronidase null (GUSB−; gusmps/gusmps). The GUSB− mice with mucopolysaccharidosis type VII (MPS VII), like a large number of human patients with similar diseases, have systemic lysosomal storage disease that leads to premature death. Congenic GUSB+, Lineagelo, Sca-1hi, c-Kithi, Hoechstlo HSC, at doses of 30, 100, 250, and 425 cells, implanted and amplified in adult W41/W41, gusmps/gusmps recipients in a dose-dependent manner. At autopsy, primary recipients of 100 and 425 donor cells had histologically identifiable donor GUSB+ cells in multiple sites and showed both myeloid and lymphoid expansion in bone marrow. Donor cells were rare in the liver and spleen of 100-cell recipients, but lysosomal storage was significantly reduced. The life span was significantly extended in engrafted recipients of 250 (36.7 ± 3.84 weeks, p = 0.0316) and 425 (40.7 ± 1.53 weeks, p = 0.0033) cells compared to untreated mice (26.4 ± 1.53 weeks). Secondary hosts of marrow from the recipients of 425 cells demonstrated continued expansion of the GUSB+ cells. Results indicate the genetically myeloablated MPS VII mice can be used to trace and enumerate donor cells long-term and to follow early engraftment events in situ.